Cite

    Dechang Chen et al.. “Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China.” Journal of medical economics, vol. 21, 2018, pp. 301–307. http://access.bl.uk/ark:/81055/vdc_100057147581.0x000024